Research Coordinator (2024 - 2025)
Emily Kim earned a B.S. in Psychology with a focus on Neuroscience from The Pennsylvania State University Schreyer Honors College and a minor in Natural Science. Since 2021, she has been involved in cardiology clinical research, focusing on pediatric lymphatic and cardiovascular conditions as well as adult cardiac electrophysiology. Emily joined the Goyal Lab in September 2024, where she coordinates N-of-1 trials for deprescribing beta-blockers in HFpEF patients and supports various other ongoing research studies related to HFpEF and Amyloidosis. Emily looks forward to working with a diverse patient population and gaining more experience in clinical research and medicine through the program.